thumbnail image
Beijing SBS Genetech Co.,Ltd.
Beijing SBS Genetech Co.,Ltd.
broken image

from China, for the World

for Superior Biology Services since 2000

  • Home
  • Product 
    • All Products
    • Custom Services
    • Catalog Products
    • Isothermal Portfolio
    • Nucleic Acid Related
    • Enzymes
    • Innovative Systems
  • About 
    • About SBS
    • Achievements
    • Ecosystem
    • Legal Statement
    • Contact
  • SynBio 
    • SBS Insights
    • Synthetic Biology
    • Bio-Enzyme
    • HMF
    • PHA 3D Printing Filament
  • …  
    • Home
    • Product 
      • All Products
      • Custom Services
      • Catalog Products
      • Isothermal Portfolio
      • Nucleic Acid Related
      • Enzymes
      • Innovative Systems
    • About 
      • About SBS
      • Achievements
      • Ecosystem
      • Legal Statement
      • Contact
    • SynBio 
      • SBS Insights
      • Synthetic Biology
      • Bio-Enzyme
      • HMF
      • PHA 3D Printing Filament
  • 0
    • Login
Beijing SBS Genetech Co.,Ltd.
Beijing SBS Genetech Co.,Ltd.
broken image

from China, for the World

for Superior Biology Services since 2000

  • Home
  • Product 
    • All Products
    • Custom Services
    • Catalog Products
    • Isothermal Portfolio
    • Nucleic Acid Related
    • Enzymes
    • Innovative Systems
  • About 
    • About SBS
    • Achievements
    • Ecosystem
    • Legal Statement
    • Contact
  • SynBio 
    • SBS Insights
    • Synthetic Biology
    • Bio-Enzyme
    • HMF
    • PHA 3D Printing Filament
  • …  
    • Home
    • Product 
      • All Products
      • Custom Services
      • Catalog Products
      • Isothermal Portfolio
      • Nucleic Acid Related
      • Enzymes
      • Innovative Systems
    • About 
      • About SBS
      • Achievements
      • Ecosystem
      • Legal Statement
      • Contact
    • SynBio 
      • SBS Insights
      • Synthetic Biology
      • Bio-Enzyme
      • HMF
      • PHA 3D Printing Filament
  • 0
    • Login
Beijing SBS Genetech Co.,Ltd.
Go Back
RNAi Control

RNAi Control

We can provide positive controls, universal negative controls without homology with the target gene sequence, and negative controls with selected siRNA sequence scrambled. All these RNAi controls are purified by HPLC.
Select
Quantity
Coming soon
Add to cart
More Details

All products have special prices for bulk purchase, please contact for more details if required.

 

Negative Control

We can provide universal negative controls without homology with the target gene sequence and negative controls with selected siRNA sequence scrambled.

  • siRNA experiments should have negative controls.
  • Universal negative controls are those with no homology to the sequence of the gene of interest.
  • Scrambled negative control has the same composition as selected siRNA sequences, but it has no obvious homology to the mRNA.
  • Negative control need to be confirmed that it has no homology to other genes in the target cell of interest.
  • The universal negative control sequence is derived from Caenorhabditis elegans, which is also a segment referenced in a large number of literature. All mammals share no homology with this sequence, so it is suitable for the study of different genes in mammals such as rat, mouse, human.

 

FAM-Labeling Negative Control

We can provide universal negative controls with FAM labeling that has no homology to the sequence of the gene of interest.

  • Universal negative controls are those with no homology to the sequence of the gene of interest;
  • By labeling the fluorescence, it is convenient to observe the transfection under a fluorescence microscope.
  • Can be used to optimize transfection conditions and evaluate transfection efficiency;
  • Excellent pH tolerance and more stable in living cells.

 

Positive Control

Positive controls are important in your experimental system. When you see the expected experimental results for the siRNA positive control, you can ensure that your transfection, RNA extraction, and detection assay are reliable.

Commonly used siRNA positive controls:

  • LaminA/C
  • GFP274
  • Luciferase GL2
  • MAPK1
  • Beta-Actin
  • Vimentin
  • P53
  • GAPDH
  • Cyclophilin B

 

Avoiding Off Target Effect Control

In mammals, off-target effects are of great concern for RNAi research. There are numerous reports that a single siRNA affects the expression of multiple genes. Therefore, a large number of studies have focused on performing experiments with multiple siRNAs targeting different regions on the same gene and then analyzing the respective effects on gene expression. The ideal result is that siRNAs targeting different regions produce similar interfering effects on the same target gene. We can design multiple pairs of siRNA oligos for the same target gene for you to solve the problem of off-target effects.

 

 

Only for research and not intended for treatment of humans or animals

 

 

Journals Using SBS Genetech Products                                       Universities Using SBS Genetech Products

 

 

SBS Genetech is a long-term sponsor of Cold Spring Harbor Laboratory

 

  • Featured Publications

    We are honored to create value for our customers and facilitate the development of science

    Congratulations to Our Customer for Published in Nature Communications (IF: 18)!
    2023年10月1日
    On September 28th, a breakthrough paper was published by researchers from Sun Yat-sen University...
    Read more...
    Congratulations to Our Customer for Published in Advanced Materials (IF: 32)!
    2023年8月27日
    On August 17th, a research paper entitled "Cellular Membrane-Engineered Nanovesicles as Three...
    Read more...
    Congratulations to Our Customer for Published in Molecular Plant (IF: 22)!
    2023年4月12日
    On April 6th, a research paper entitled "Phosphorylation of OsRbohB by the CaM-dependent protein...
    Read more...

SBS Genetech © Copyright 2000-2023

 

from China, for the World

for Superior Biology Services since 2000

    Home
    Journals
    Contact
    Posts
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More